Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 24, 2001

View Archived Issues

Low Share Prices, Cash Positions Expected To Trigger M&A Activity

Some EU Member States Resist Lifting Moratorium On GMOs

French Government Agrees On Measures To Support Biotech

Tissue Engineering Draws Much Interest At German Trade Fair

Axxima Raises EUR30.6M In Third Financing Round

IntegraGen Secures Access To Obesity, Diabetes Gene Data

Berna Biotech, Bachem Enter Joint Venture For Peptide Vaccines

Other News To Note

Transgene Takes Gene Therapy Product Into Phase II Studies

ReGen Raising Funds To Move Colostrinin Trials Forward

De Novo, Roche Collaborate On Chemical Design Platform

MediGene Gets Positive Results In First Genital Warts Phase III

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.